2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
5
Barrett Esophagus
3
Pancreatic Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Stomach Neoplasms
1
Liver Neoplasms
1
Liver Cirrhosis
1
Fibrosis
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breath Test
1
Breast Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Blood Specimen Collection
8
Magnetic Resonance Spectroscopy
5
Pentoxifylline
4
Liver Transplantation
4
Tenofovir
3
Specimen Handling
3
High-Energy Shock Waves
3
Tocopherols
2
Sorafenib
2
Simvastatin
2
Low-Level Light Therapy
2
Gemcitabine
2
tremelimumab
1
sonidegib
1
sofosbuvir-velpatasvir drug combination
1
ruxolitinib
1
peginterferon alfa-2a
1
navitoclax
1
maltodextrin
1
hepatitis B hyperimmune globulin
1
esmolol
1
epigallocatechin gallate
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
atezolizumab
1
apixaban
1
alpha-Tocopherol
1
adefovir dipivoxil
1
Viusid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fibrosis
×
Breath Tests
×
Clear all
NCT04620538
2026-03-30
VOCAL
Imperial College London
Completed
56 enrolled